Catalog No.
Product Name
Application
Product Information
Citations
-
Drug Impurity
Cinacalcet impurity 13 is a known impurity associated with the drug Cinacalcet, which acts as a calcimimetic agent targeting the calcium-sensing receptor (CaSR). This impurity may be generated during the synthesis of Cinacalcet and is useful for analytical and quality control purposes in pharmaceutical development. Researchers can utilize this compound to assess the purity and stability of Cinacalcet formulations in regulatory submissions. -
Drug Impurity
Diclofenac Impurity 6 is a chemical impurity associated with Diclofenac, a widely used nonsteroidal anti-inflammatory drug (NSAID). This impurity is significant for analytical research and quality control in pharmaceutical development, aiding in the assessment of drug purity and stability. Its presence may impact the pharmacological properties of Diclofenac, making it essential for studies focused on drug formulation and regulatory compliance. -
Drug Impurity
Albendazole Impurity 3 is a known impurity associated with the anthelmintic agent Albendazole. This compound is primarily investigated for its role in assessing the purity and stability of Albendazole formulations. Its identification is essential for quality control and regulatory compliance in drug development and manufacturing processes. -
Drug Impurity
Atenolol impurity 7 is a known impurity associated with the beta-blocker Atenolol. Its characterization is crucial for ensuring the quality and safety of Atenolol formulations. Researchers utilize this compound to investigate the effects of impurities on drug efficacy and stability, aiding in the development of more robust pharmaceutical formulations. -
Drug Impurity
Quetiapine impurity 16 is a known impurity of the atypical antipsychotic quetiapine. It is primarily utilized in pharmacological studies to assess the purity and quality of quetiapine formulations. This compound plays a crucial role in understanding the chemical profile and potential effects of quetiapine in therapeutic contexts. Analytical methods such as HPLC may be employed for its detection and quantification in drug development processes. -
Drug Impurity
Ibuprofen impurity 9 is identified as a degradation product of ibuprofen. This compound serves as a critical reference standard for quality control in pharmaceutical formulations and helps in the assessment of drug purity. Its analysis is essential for ensuring compliance with regulatory standards in drug development and manufacturing processes. -
Drug Impurity
Neratinib impurity 13 is a chemical impurity associated with the anti-cancer agent Neratinib. As a drug impurity, it provides critical insights into the stability and quality control of Neratinib formulations. It serves as an important reference standard for analytical and formulation studies, assisting in the evaluation of drug efficacy and safety. -
Drug Impurity
Rivaroxaban impurity 45 is a known impurity of the anticoagulant drug Rivaroxaban, which acts as a direct factor Xa inhibitor. This compound is essential for the analysis of drug quality and purity, serving as a reference standard in pharmaceutical and biochemical research. Its characterization is critical for the development of analytical methods and for ensuring compliance with regulatory standards in clinical studies and drug manufacturing processes. -
Drug Impurity
Azithromycin impurity 23 is identified as a minor impurity related to the antibiotic Azithromycin. Its presence is relevant for drug quality control and analysis, particularly in pharmaceutical research and development settings. This impurity can affect the overall purity and efficacy of Azithromycin, making it crucial for studies focused on drug formulation and stability. -
Drug Impurity
Duloxetine impurity 14, also known as Duloxetine succinamide, is a chemical impurity associated with the synthesis of Duloxetine. It serves as a crucial reference standard for assessing the purity and quality of Duloxetine in pharmaceutical formulations. Research applications include method development and validation in analytical chemistry, as well as stability studies of Duloxetine-containing products. -
Drug Impurity
Famotidine impurity 2, also known as Famotidine impurity A, is a chemical impurity associated with the pharmaceutical compound Famotidine. Its presence is essential for analytical and quality control applications in drug development processes. This impurity serves as a critical reference standard for the assessment of Famotidine's purity and compliance with regulatory standards during formulation and stability studies. -
Drug Impurity
Telmisartan impurity 1, also known as 4'-Bromomethyl-2-cyanobiphenyl, serves as a drug impurity associated with Telmisartan. This compound is significant for quality control in pharmaceutical formulations and is utilized in the development and validation of analytical methods for telmisartan quantification. Its characterization can aid in assessing the purity and stability of telmisartan during research and production processes. -
Drug Impurity
Ranitidine impurity 14 is a known impurity associated with the drug Ranitidine. This compound is utilized primarily in analytical research to assess the purity and quality of pharmaceutical formulations containing Ranitidine. Its presence can impact drug efficacy and safety, making it significant for quality control and regulatory compliance in drug development. -
Drug Impurity
Paliperidone impurity 8 is a known impurity associated with the antipsychotic medication Paliperidone. It is utilized primarily in the quality control and regulatory compliance of pharmaceutical formulations to ensure the purity and safety of the drug. This reagent serves as an essential reference standard for analytical methods, including chromatography, to assess the presence and concentration of this impurity in drug products. -
Drug Impurity
Dacomitinib impurity 14 is identified as a chemical impurity associated with Dacomitinib, a pan-ErbB receptor tyrosine kinase inhibitor. The presence of this impurity is relevant for the characterization and quality control of Dacomitinib in pharmaceutical formulations. This reagent may be utilized in research studies focused on the analytical profiling and assessment of drug purity, as well as in the development of related therapeutic agents. -
Drug Intermediate
GS-1427 intermediate-1 is a crucial intermediate in the synthesis of the compound GS-1427. This reagent plays an essential role in the production and development of therapeutic agents targeting specific biological pathways. Its unique chemical structure supports researchers in investigating potential pharmaceutical applications within various domains of drug discovery. -
Drug Impurity
Sorafenib impurity 5 is a defined impurity of the multi-kinase inhibitor Sorafenib, primarily targeting RAF kinases, VEGFR, and PDGFR. This reagent is essential for quality control and analytical purposes in pharmaceutical research, enabling the assessment of purities in the synthesis of Sorafenib. It aids researchers in understanding the chemical composition and potential impacts of impurities on drug efficacy and safety profiles. -
Drug Intermediate
2-Deoxy-D-ribose 1-phosphate is a key intermediate involved in the metabolism of phosphoinositides. This compound is particularly relevant in studies of cellular signaling pathways and membrane dynamics in neurological research. Its utilization can provide insights into the biochemical mechanisms that underlie various neurological processes and drug development. -
Drug Impurity
Brimonidine impurity 3 is a chemical impurity associated with the drug Brimonidine, primarily targeting adrenergic receptors. This compound is relevant for quality control in pharmaceutical formulations and can be utilized to study the stability and degradation pathways of Brimonidine. Its characterization contributes to the development of safer and more effective drug products. -
Drug Impurity
Tandospirone impurity 3 is a chemical impurity associated with the drug Tandospirone, a known anxiolytic agent targeting serotonin receptors. This impurity is critical for quality control and analytical research, ensuring the integrity and safety of pharmaceutical formulations containing Tandospirone. Its characterization can aid in understanding the metabolic pathways and potential effects of Tandospirone in various biological contexts. -
Drug Impurity
Prednisolone impurity 7 is a known impurity associated with the corticosteroid prednisolone. This compound is primarily utilized in quality control and analytical studies to assess the purity of prednisolone formulations. It serves as an important reference standard for researchers engaged in pharmaceutical research and development, ensuring compliance with regulatory guidelines and safety assessments. -
Drug Impurity
Buspirone impurity 3 is a known impurity of the anxiolytic agent buspirone. As a chemical research reagent, it plays a critical role in the analysis and characterization of drug purity and formulation. This compound is utilized in the development and quality control of pharmaceutical products to ensure compliance with regulatory standards. -
Drug Impurity
Apixaban impurity 6 is a noted impurity associated with the anticoagulant Apixaban. It serves as a reference standard for quality control and analytical purposes in pharmaceuticals. This compound is crucial for evaluating the purity of Apixaban formulations and ensuring compliance with regulatory standards in drug manufacturing and testing. -
Drug Impurity
Fluphenazine decanoate impurity 1 is identified as a drug impurity associated with Fluphenazine decanoate. This impurity serves as a critical marker for quality control and analytical studies in pharmaceutical development. It is crucial for researchers assessing the purity and stability of Fluphenazine formulations, contributing to the overall understanding of drug safety and efficacy. -
Drug Impurity
Meloxicam impurity 3 is a synthetic impurity associated with the nonsteroidal anti-inflammatory drug (NSAID) Meloxicam. It is primarily studied for its role in drug quality control and analytical chemistry applications. Understanding the characteristics and behavior of this impurity can aid in the development of safer and more effective pharmaceutical formulations, as well as in compliance with regulatory standards. -
Drug Impurity
Beclometasone dipropionate impurity 11 is a characterized impurity of the corticosteroid beclometasone dipropionate, primarily serving as a reference standard in analytical chemistry. It is utilized in the quality control and assessment of pharmaceutical formulations containing beclometasone dipropionate. This impurity aids in determining the purity and stability of drug products, contributing to regulatory compliance and ensuring product safety and efficacy. -
Drug Impurity
Rosuvastatin impurity 13 is a known impurity of the cholesterol-lowering agent Rosuvastatin, primarily utilized in drug quality control and analytical chemistry. It serves as an important reference standard for assessing the purity and stability of Rosuvastatin formulations. This compound is essential for ensuring compliance with regulatory standards during the development and manufacture of pharmaceutical products. -
Simethicone Impurity
Octamethyl-1,7-tetrasiloxanediol is a siloxane compound that serves as an impurity in Simethicone formulations. It is relevant in chemical research focused on identifying and characterizing impurities in silicone-based compounds. The compound's structural properties may also be investigated for their potential impact on the efficacy and safety profiles of silicone-derived products. -
Drug Impurity
Donepezil impurity 5, also known as Deoxydonepezil, is a recognized impurity associated with the pharmaceutical agent Donepezil. This compound serves as a critical reference standard for quality control and analytical studies in the development and validation of Donepezil formulations. Its characterization aids in ensuring the purity and safety of Donepezil-containing products in pharmaceutical research. -
Drug Impurity
Aceclofenac impurity 4, also known as Aceclofenac benzyl ester, is a recognized impurity associated with Aceclofenac. This compound is primarily utilized in the pharmaceutical industry for quality control and analytical purposes to assess the purity of Aceclofenac formulations. Its presence and characterization contribute to understanding the compound's stability and overall safety profile in drug development and manufacturing processes. -
Drug Impurity
Nimesulide impurity 1 is a known impurity of the analgesic and anti-inflammatory agent Nimesulide, primarily identified in quality control settings. This compound is essential for validating the purity of Nimesulide in pharmaceutical formulations and can be utilized in research focusing on drug metabolism and impurity profiling. Its presence can influence pharmacological studies and regulatory compliance assessments. -
Drug Impurity
Brimonidine impurity 2 is a known impurity associated with the drug Brimonidine, a selective alpha-2 adrenergic agonist. This compound is used in the research and development of pharmaceutical formulations to identify and quantify impurities in drug products. Analyzing this impurity is crucial for ensuring drug safety and efficacy, as well as for complying with regulatory standards in drug development. -
Drug Impurity
Citalopram impurity 3 is a known impurity associated with the selective serotonin reuptake inhibitor (SSRI) Citalopram. This compound serves as a reference standard for analytical testing and quality control in pharmaceutical development. Its identification is crucial for ensuring the purity and safety of Citalopram formulations in research and clinical applications. -
Drug Impurity
(Z)-3-propyl-2-(o-tolylimino)thiazolidin-4-one serves as a drug impurity with potential significance in pharmaceutical research. This compound may be important for the evaluation of drug stability, efficacy, and safety profiles during development. Its presence can influence the analytical methods employed in drug formulation and quality control studies, making it relevant for ensuring regulatory compliance and therapeutic integrity. -
Ambroxol hydrochloride Impurity
trans-4-(6,8-Dibromo-1,2-dihydroquinazolin-3(4H)-yl)cyclohexanol hydrochloride is an impurity of Ambroxol hydrochloride, functioning primarily as a chemical marker for quality control in pharmaceutical formulations. This compound can be useful in studies focusing on the metabolic pathways and degradation of Ambroxol, enabling researchers to assess the purity and stability of the main drug compound. Its characterization contributes to the understanding of related quinazoline derivatives in medicinal chemistry. -
Drug Impurity
Diclofenac impurity 4 sodium is a characterized impurity of Diclofenac sodium, primarily identified in pharmaceutical formulations. Its presence can influence drug efficacy and safety profiles, making it important for analytical research and quality control in drug development. This impurity serves as a reference standard in pharmacological studies and stability testing, aiding in the assessment of Diclofenac sodium purity and composition. -
Drug Impurity
Mesalazine impurity 9 is a known impurity associated with the anti-inflammatory drug mesalazine, primarily targeting the inhibition of leukotriene synthesis. This compound is significant for quality control in pharmaceutical research and development, particularly in assessing the purity of mesalazine formulations. Its characterization is essential for ensuring the safety and efficacy of mesalazine-based therapies. -
Drug Impurity
Flurbiprofen impurity 4 is a known impurity associated with Flurbiprofen, a nonsteroidal anti-inflammatory drug (NSAID). It serves as a critical reference standard for quality control in pharmaceutical development and regulatory compliance. This compound is essential for impurity profiling and evaluating the purity of Flurbiprofen formulations in research and development settings. -
Drug Impurity
Mycophenolate impurity 5 (Mycophenolic acid lactone) is an impurity associated with Mycophenolate. This compound is relevant for assessing the purity of Mycophenolate preparations in pharmaceutical research. Its characterization can aid in understanding the potential impact of impurities on drug efficacy and safety profiles in clinical applications. -
Drug Impurity
Irbesartan impurity 7 is a known impurity of the antihypertensive agent Irbesartan, primarily targeting the angiotensin II type 1 receptor. This reagent is essential for quality control and regulatory compliance in pharmaceutical development. Its analysis contributes to ensuring the safety and efficacy of Irbesartan formulations, making it a valuable tool in drug testing and characterization. -
Drug Impurity
Tamsulosin impurity 20 is a structural impurity related to the alpha-1 adrenergic antagonist Tamsulosin. This compound is primarily used for quality control in pharmaceutical research, particularly in the analysis of drug purity and characterization. Its presence in formulations can provide insights into synthesis processes and contribute to the optimization of drug manufacturing practices. -
Drug Impurity
Carvedilol impurity 3 is a drug impurity associated with Carvedilol, a non-selective beta-blocker. Its presence in formulations can impact the pharmacokinetics and safety profile of the drug, making it relevant for analytical and quality control applications in pharmaceutical research. This compound is utilized in the assessment of drug purity and regulatory compliance testing in the development of Carvedilol-based therapeutics. -
Drug Impurity
Clindamycin phosphate impurity 6, also known as Clindamycin 4-Phosphate, is a key impurity associated with Clindamycin phosphate. This compound is relevant in the field of pharmaceutical analysis and quality control, serving as a critical marker for assessing the purity of clindamycin formulations. Its identification is essential for ensuring compliance with regulatory standards and for studying the pharmacological properties and stability of clindamycin-based therapies. -
Drug Impurity
Levothyroxine impurity 9 is a chemical impurity associated with levothyroxine, a synthetic thyroid hormone. This compound is primarily used in research to study the effects of drug impurities on pharmacokinetics and pharmacodynamics. Its characterization and quantification are crucial for ensuring the quality and safety of levothyroxine formulations. As such, it serves as an essential tool in pharmaceutical development and quality control processes. -
Drug Impurity
Metronidazole impurity 2 (2-Methyl-5-nitro-1H-imidazole) is a recognized impurity found in Metronidazole. This compound is important for analytical studies of drug purity and stability, as well as for the development and optimization of pharmaceutical formulations. Its biological activity and role in metabolic pathways make it relevant for research in drug development and quality control processes. -
Drug Impurity
Chlorthalidone impurity 6 is a known impurity of the drug Chlorthalidone, a thiazide-like diuretic primarily targeting kidney function. Its presence can impact the efficacy and safety profile of pharmaceutical formulations. This reagent is essential for analytical research and quality control in drug development, facilitating the assessment of drug purity and compliance with regulatory standards. -
Drug Impurity
Fluphenazine decanoate impurity 5, also known as Fluphenazine octanoate, is a recognized impurity associated with Fluphenazine decanoate. Its primary relevance lies in pharmacological and toxicological studies, where it may be evaluated for effects on drug purity and stability. This compound is crucial for ensuring the safety and efficacy of formulations containing Fluphenazine decanoate in various therapeutic applications. -
Drug Impurity
Sildenafil impurity 7 is a known impurity of the phosphodiesterase type 5 (PDE5) inhibitor, Sildenafil. This compound is essential for quality control in pharmaceutical formulation, allowing for the assessment of purity and the identification of potential contaminants in Sildenafil production. Research applications include analytical method development and regulatory compliance in the pharmaceutical industry. -
Drug Impurity
Cinacalcet impurity 12 is a chemical impurity associated with the antihyperparathyroid agent cinacalcet, which primarily targets calcium-sensing receptors. This compound is utilized in analytical chemistry and quality control applications to ensure the purity and efficacy of cinacalcet formulations. Its characterization is essential for the development and validation of pharmacological assays, contributing to compliance with regulatory standards in drug manufacturing. -
Drug Impurity
Pinaverium impurity 1 is a chemical impurity associated with Pinaverium, a known drug utilized in the treatment of gastrointestinal disorders. This impurity serves as a critical reference standard for quality control and analytical studies in pharmaceutical research. It aids in the assessment of drug purity and the identification of potential degradation products during formulation development.
